2007
DOI: 10.1590/s0004-27492007000400024
|View full text |Cite
|
Sign up to set email alerts
|

Córnea verticilata - marcador clínico da doença de Fabry: relato de caso

Abstract: Fabry's disease is a rare X-linked lysosomal storage disorder of glycosphingolipid (GL) metabolism, caused by a deficiency of alpha-galactosidase A activity. The progressive accumulation of GL in tissues results in the clinical manifestations of the disease, that are more evident in hemizygous males, and include angiokeratomas, acroparesthesia, cornea verticillata, cardiac and kidney involvement, cerebrovascular manifestations. A family with Fabry's disease including 2 female patients and 3 male patients is re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0
2

Year Published

2011
2011
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 12 publications
(5 reference statements)
0
1
0
2
Order By: Relevance
“…Many female carriers have normal α-Gal A enzyme activity, although, demonstration of decreased α-Gal A enzyme activity is diagnostic of the carrier state. The screening for female carriers can be done with the ophthalmic examination based on the presence of cornea verticillata present in 70-90% of females carrier (5,9) .…”
Section: Discussionmentioning
confidence: 99%
“…Many female carriers have normal α-Gal A enzyme activity, although, demonstration of decreased α-Gal A enzyme activity is diagnostic of the carrier state. The screening for female carriers can be done with the ophthalmic examination based on the presence of cornea verticillata present in 70-90% of females carrier (5,9) .…”
Section: Discussionmentioning
confidence: 99%
“…Nos homens, o diagnóstico definitivo é feito pela detecção da atividade da enzima α galactosidase. Essa atividade é inferior a 3% do normal (CORDEIRO et al, 2007).…”
Section: Como Em Pacientes Que Dotam a Forma Clássica Da Doença O Comprometimento Da Funçãounclassified
“…A agalsidase alfa (Replagal®), sintetizada em cultura de fibroblastos humanos incrementados com promotores para a transcrição do gene da α -galactosidase, atua como catalisadora da hidrólise de Gb3, clivando o resíduo terminal da molécula. Há também outra enzima, algasidase beta (Fabrazyme®), estrutural e funcionalmente similar à primeira, mas produzida em ovários de hamsters chineses e dotada de diferente composição glicídica, resultando em respostas distintas (CORDEIRO et al, 2007).…”
Section: Como Em Pacientes Que Dotam a Forma Clássica Da Doença O Comprometimento Da Funçãounclassified